Effectiveness and Safety of the Clareon Monofocal Intraocular Lens: Outcomes from a 12-Month Single-Arm Clinical Study in a Large Sample.

Robert LehmannAndrew MaxwellDavid M LubeckRaymond FongThomas R WaltersAnna Fakadej

Published in: Clinical ophthalmology (Auckland, N.Z.) (2021)

Results of this study supported effectiveness and safety of the SY60CL IOL. Visual acuity outcomes with the SY60CL IOL exceeded the SPE rates for monocular CDVA and AEs were within the limit of historic SPE rates. (Model number SY60WF is the Clareon lens approved by the FDA.).

Keyphrases

ms ms
solid phase extraction
metabolic syndrome
insulin resistance
weight loss
mass spectrometry
glycemic control